These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 24168256

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interleukin-28B gene non-TT allele strongly predicts treatment failure for genotype 1 infected chronic hepatitis C patients with advanced fibrosis: a case control study.
    Hu CC, Lin CL, Chang LC, Chien CH, Chen LW, Liu CJ, Chien RN.
    BMC Infect Dis; 2015 Mar 26; 15():156. PubMed ID: 25888020
    [Abstract] [Full Text] [Related]

  • 4. SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China.
    Li Y, Wang J, Wang J, Xiao Y, Xu B, Li H, Yang L, Hao X, Ma Y.
    Virol J; 2017 Mar 23; 14(1):62. PubMed ID: 28335783
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C.
    Świątek-Kościelna B, Kałużna E, Strauss E, Nowak J, Bereszyńska I, Gowin E, Wysocki J, Rembowska J, Barcińska D, Mozer-Lisewska I, Januszkiewicz-Lewandowska D.
    World J Gastroenterol; 2017 Jun 07; 23(21):3815-3824. PubMed ID: 28638221
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C.
    Fukuhara T, Taketomi A, Motomura T, Okano S, Ninomiya A, Abe T, Uchiyama H, Soejima Y, Shirabe K, Matsuura Y, Maehara Y.
    Gastroenterology; 2010 Nov 07; 139(5):1577-85, 1585.e1-3. PubMed ID: 20708617
    [Abstract] [Full Text] [Related]

  • 9. The complete title: The effect of interleukin-28B rs12979860 polymorphism on the therapeutic response of Moroccan patients with chronic hepatitis C.
    Nadia K, Hicham E, Reda TM, Nadia T, Elarbi B, Saâd E, Mimoun Z, Saâd M.
    Gene; 2015 Aug 15; 568(1):31-4. PubMed ID: 25958342
    [Abstract] [Full Text] [Related]

  • 10. Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4.
    De Nicola S, Aghemo A, Rumi MG, Galmozzi E, Valenti L, Soffredini R, De Francesco R, Prati GM, D'Ambrosio R, Cheroni C, Donato MF, Colombo M.
    Hepatology; 2012 Feb 15; 55(2):336-42. PubMed ID: 21932415
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection.
    Charlton MR, Thompson A, Veldt BJ, Watt K, Tillmann H, Poterucha JJ, Heimbach JK, Goldstein D, McHutchison J.
    Hepatology; 2011 Jan 15; 53(1):317-24. PubMed ID: 21254179
    [Abstract] [Full Text] [Related]

  • 12. [PROGNOSTIC VALUE OF THE COMBINATION OF BLOOD GROUP SPECIFICITY AND INTERLEUKIN 28B GENE POLYMORPHISM FOR ESTIMATION OF EFFICIENCY OF THERAPY WITH THE USE OF PEGYLATED INTERFERON α-2 AND RIBAVARIN IN PATIENTS WITH CHRONIC GENOTYPE 1 HEPATITIS C].
    Ogurtsov PP, Kukhareva EI.
    Klin Med (Mosk); 2016 Jan 15; 94(3):224-30. PubMed ID: 27522730
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association of rs12979860 and rs8099917 polymorphisms near IL28B with SVR in hepatic allograft recipients with HCV recurrence undergoing PEG-IFN/RBV therapy: a meta-analysis.
    Zhang L, Lu Q, Yang Z, Wang X, Cai L, Liu X, Liao R, Yang X, Chen Y, Yang Z.
    Hum Immunol; 2014 Dec 15; 75(12):1268-75. PubMed ID: 25225180
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Relationship between the genetic variation in interleukin 28B and response to antiviral therapy in patients with chronic hepatitis C.
    Xie JQ, Guo XY, Zhang XH, Lin BL, Xie DY, Gao ZL, Wang GS, Zhao ZX.
    Chin Med J (Engl); 2012 Jul 15; 125(13):2334-8. PubMed ID: 22882858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.